Clinical Trial 46499

Oceanside, CA 92056


A Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone: Monotherapy in the Treatment of Patients with Major Depressive Episodes or have Associated depressive episodes with Bipolar I or Bipolar II Disorder (Bipolar Depression)

Who is Qualified?:

  • Participants who are generally healthy and between 18-75 years old.
  • Participants who have been in a depressive episode for at least 2 weeks but not more than 6 months. (Recurrent depressive symptoms are ok if you have 6-8 good weeks in between each episode.)
  • No medication history necessary to qualify.
  • No previous diagnosis needed to qualify.
  • Insurance not required to qualify.
  • Participants willing to stop all psychiatric medications they are currently taking.
  • Diagnosis of just depression or any type of Bi-Polar is allowed.

Qualified Participants Can Receive:
  • $50 in Compensation after each completed appointment.
  • Travel or gas reimbursement up to $53 per visit.
  • Lumateperone medication at no cost. (FDA approved but not yet for the treatment of depressive symptoms.)
  • Free labs and blood work during the initial visit and through the study.

How long are these studies?
  • This study is 10-12 Weeks long with 9 scheduled visits at our office in Oceanside.
  • Studies are voluntary in the sense that you can stop at any moment; You are paid after each completed appointment $50 plus transportation reimbursement up to $53 per visit.
  • Each visit will be about an hour besides the initial screening visit which is normally 4-5 hours.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.